MPS1
£50m oncology fund pays out
April 24, 2013Research and Development, Sales and Marketing Cancer, ICR, MPS1
The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
